Minerva Neurosciences (NERV) Share-based Compensation (2014 - 2026)
Minerva Neurosciences posted quarterly Share-based Compensation of $8.7 million for Q1 2026, up 2830.5% year-on-year from $297229.0 in Q1 2025, and up 1797.55% on a QoQ basis from $459028.0 in Q4 2025.
Minerva Neurosciences (NERV) has 13 years of Share-based Compensation data on file, last reported at $8.7 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 2830.5% year-over-year to $8.7 million; the trailing twelve-month figure through Mar 2026 stood at $9.7 million (up 722.74% YoY), and the FY2025 full-year result was $1.3 million, changed 0.14% from the prior year.
- Share-based Compensation for Q1 2026 stood at $8.7 million, up from $459028.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $8.7 million in Q1 2026 and bottomed at $249650.0 in Q4 2024.
- The 5-year median for Share-based Compensation is $438849.0 (2024), against an average of $1.0 million.
- The widest annual swing landed in 2023, when Share-based Compensation plunged 64.24%; it then jumped 2830.5% in 2026.
- A 5-year view of Share-based Compensation shows it stood at $947684.0 in 2022, then tumbled by 35.52% to $611064.0 in 2023, then tumbled by 59.15% to $249650.0 in 2024, then jumped by 83.87% to $459028.0 in 2025, then surged by 1797.55% to $8.7 million in 2026.
- The last three Share-based Compensation figures came in at $8.7 million (Q1 2026), $459028.0 (Q4 2025), and $272897.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 892,057.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 305,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 166.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 257.40 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.15 Mn |
| 10 | Minerva Neurosciences | 215.11 Mn | 215.11 Mn | - | 8.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.71 Mn |
| Mar 31, 2026 | 8.71 Mn |
| Dec 31, 2025 | 459,028.00 |
| Dec 31, 2025 | 459,028.00 |
| Sep 30, 2025 | 272,897.00 |
| Sep 30, 2025 | 272,897.00 |
| Jun 30, 2025 | 298,218.00 |
| Jun 30, 2025 | 298,218.00 |
| Mar 31, 2025 | 297,229.00 |
| Mar 31, 2025 | 297,229.00 |
| Dec 31, 2024 | 249,650.00 |
| Dec 31, 2024 | 249,650.00 |
| Sep 30, 2024 | 307,708.00 |
| Sep 30, 2024 | 307,708.00 |
| Jun 30, 2024 | 329,318.00 |
| Jun 30, 2024 | 329,318.00 |
| Mar 31, 2024 | 438,849.00 |
| Mar 31, 2024 | 438,849.00 |
| Dec 31, 2023 | 611,064.00 |
| Dec 31, 2023 | 611,064.00 |
| Sep 30, 2023 | 371,943.00 |
| Sep 30, 2023 | 371,943.00 |
| Jun 30, 2023 | 608,915.00 |
| Jun 30, 2023 | 608,915.00 |
| Mar 31, 2023 | 376,459.00 |
| Mar 31, 2023 | 376,459.00 |
| Dec 31, 2022 | 947,684.00 |
| Dec 31, 2022 | 947,684.00 |
| Sep 30, 2022 | 1.04 Mn |
| Sep 30, 2022 | 1.04 Mn |
| Jun 30, 2022 | 1.07 Mn |
| Jun 30, 2022 | 1.07 Mn |
| Mar 31, 2022 | 1.05 Mn |
| Mar 31, 2022 | 1.05 Mn |
| Dec 31, 2021 | 1.20 Mn |
| Dec 31, 2021 | 1.20 Mn |
| Sep 30, 2021 | 1.11 Mn |
| Sep 30, 2021 | 1.11 Mn |
| Jun 30, 2021 | 1.38 Mn |
| Jun 30, 2021 | 1.38 Mn |
| Mar 31, 2021 | 1.52 Mn |
| Mar 31, 2021 | 1.52 Mn |
| Dec 31, 2020 | 1.96 Mn |
| Dec 31, 2020 | 1.96 Mn |
| Sep 30, 2020 | 2.06 Mn |
| Sep 30, 2020 | 2.06 Mn |
| Jun 30, 2020 | 3.49 Mn |
| Jun 30, 2020 | 3.49 Mn |
| Mar 31, 2020 | 2.20 Mn |
| Mar 31, 2020 | 2.20 Mn |
| Dec 31, 2019 | 2.17 Mn |
| Dec 31, 2019 | 2.17 Mn |
| Sep 30, 2019 | 2.22 Mn |
| Sep 30, 2019 | 2.22 Mn |
| Jun 30, 2019 | 2.32 Mn |
| Jun 30, 2019 | 2.32 Mn |
| Mar 31, 2019 | 2.46 Mn |
| Mar 31, 2019 | 2.46 Mn |
| Dec 31, 2018 | 1.91 Mn |
| Dec 31, 2018 | 1.91 Mn |
| Sep 30, 2018 | 2.26 Mn |
| Sep 30, 2018 | 2.26 Mn |
| Jun 30, 2018 | 1.90 Mn |
| Jun 30, 2018 | 1.90 Mn |
| Mar 31, 2018 | 2.11 Mn |
| Mar 31, 2018 | 2.11 Mn |
| Dec 31, 2017 | 1.26 Mn |
| Dec 31, 2017 | 1.26 Mn |
| Sep 30, 2017 | 1.23 Mn |
| Sep 30, 2017 | 1.23 Mn |
| Jun 30, 2017 | 1.20 Mn |
| Jun 30, 2017 | 1.20 Mn |
| Mar 31, 2017 | 1.30 Mn |
| Mar 31, 2017 | 1.30 Mn |
| Dec 31, 2016 | 1.01 Mn |
| Dec 31, 2016 | 1.01 Mn |
| Sep 30, 2016 | 15,000.00 |
| Sep 30, 2016 | 15,000.00 |
| Jun 30, 2016 | 800,000.00 |
| Jun 30, 2016 | 800,000.00 |
| Mar 31, 2016 | 800,000.00 |
| Mar 31, 2016 | 800,000.00 |
| Dec 31, 2015 | 702,235.00 |
| Dec 31, 2015 | 702,235.00 |
| Sep 30, 2015 | 617,697.00 |
| Sep 30, 2015 | 617,697.00 |
| Jun 30, 2015 | 545,935.00 |
| Jun 30, 2015 | 545,935.00 |
| Mar 31, 2015 | 336,368.00 |
| Mar 31, 2015 | 336,368.00 |
| Dec 31, 2014 | 2.25 Mn |
| Dec 31, 2014 | 2.25 Mn |
| Sep 30, 2014 | 10.50 Mn |
| Sep 30, 2014 | 10.50 Mn |
| Jun 30, 2014 | 10.50 Mn |
| Jun 30, 2014 | 10.50 Mn |
| Mar 31, 2014 | 302,076.00 |
| Mar 31, 2014 | 302,076.00 |